OCT或血管造影指导复杂分叉病变PCI
这项在欧洲38个中心开展的多中心、随机、开放标签试验纳入1201例有PCI临床指征且经冠状动脉造影识别为复杂分叉病变的患者,1:1随机分配至OCT指导PCI组(600例)或血管造影指导PCI组(601例)。主要终点为心脏性死亡、靶病变心肌梗死或缺血驱动的靶病变血运重建的复合终点(MACE),中位随访2年。结果显示OCT指导组主要终点事件发生59例(10.1%),血管造影指导组83例(14.1%)(HR 0.70;95%CI 0.50~0.98;P=0.035)。结论认为在复杂冠状动脉分叉病变患者中,OCT指导PCI与2年MACE发生率较低相关。
要点
- 复杂分叉病变患者OCT指导PCI较血管造影指导降低2年MACE(10.1% vs 14.1%;HR 0.70;95%CI 0.50~0.98;P=0.035)。
- 两组左主干分叉病变比例分别为OCT组111例(18.5%)、造影组116例(19.3%)。
- 手术相关并发症OCT组41例(6.8%),血管造影组34例(5.7%)。
- 研究为欧洲38个中心的多中心、随机、开放标签试验,中位随访2年。
适用人群与场景
- 有PCI临床指征且经冠状动脉造影识别为复杂分叉病变的患者,随机分配至OCT指导PCI组(600例)或血管造影指导PCI组(601例)。
研究设计与关键结果
- 多中心、随机、开放标签试验,在欧洲38个中心纳入1201例复杂分叉病变患者,1:1随机分配至OCT指导PCI(600例)或血管造影指导PCI(601例)。
- 主要终点为心脏性死亡、靶病变心肌梗死或缺血驱动的靶病变血运重建的复合终点(MACE),中位随访2年。
- 2年时主要终点事件OCT指导组59例(10.1%),血管造影指导组83例(14.1%)(HR 0.70;95%CI 0.50~0.98;P=0.035)。
- 左主干分叉病变OCT指导组111例(18.5%),血管造影指导组116例(19.3%)。
- 手术相关并发症OCT指导组41例(6.8%),血管造影指导组34例(5.7%)。
证据类型、等级与局限
- 证据类型:多中心、随机、开放标签试验(OCTOBER,NCT03171311)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在复杂冠状动脉分叉病变患者中,OCT指导PCI与2年MACE发生率低于血管造影指导PCI相关(10.1% vs 14.1%;HR 0.70;95%CI 0.50~0.98;P=0.035)。
指南或共识出处
- OCTOBER ClinicalTrials.gov number, NCT03171311;由Abbott Vascular等资助。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Imaging-guided percutaneous coronary intervention (PCI) is associated with better clinical outcomes than angiography-guided PCI. Whether routine optical coherence tomography (OCT) guidance in PCI of lesions involving coronary-artery branch points (bifurcations) improves clinical outcomes as compared with angiographic guidance is uncertain.
METHODS: We conducted a multicenter, randomized, open-label trial at 38 centers in Europe. Patients with a clinical indication for PCI and a complex bifurcation lesion identified by means of coronary angiography were randomly assigned in a 1:1 ratio to OCT-guided PCI or angiography-guided PCI. The primary end point was a composite of major adverse cardiac events (MACE), defined as death from a cardiac cause, target-lesion myocardial infarction, or ischemia-driven target-lesion revascularization at a median follow-up of 2 years.
RESULTS: We assigned 1201 patients to OCT-guided PCI (600 patients) or angiography-guided PCI (601 patients). A total of 111 patients (18.5%) in the OCT-guided PCI group and 116 (19.3%) in the angiography-guided PCI group had a bifurcation lesion involving the left main coronary artery. At 2 years, a primary end-point event had occurred in 59 patients (10.1%) in the OCT-guided PCI group and in 83 patients (14.1%) in the angiography-guided PCI group (hazard ratio, 0.70; 95% confidence interval, 0.50 to 0.98; P = 0.035). Procedure-related complications occurred in 41 patients (6.8%) in the OCT-guided PCI group and 34 patients (5.7%) in the angiography-guided PCI group.
CONCLUSIONS: Among patients with complex coronary-artery bifurcation lesions, OCT-guided PCI was associated with a lower incidence of MACE at 2 years than angiography-guided PCI. (Funded by Abbott Vascular and others; OCTOBER ClinicalTrials.gov number, NCT03171311.).
参考来源
- Holm NR, Andreasen LD, Neghabat O, et al. OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions. N Engl J Med. 2023. PMID: 37634149. doi:10.1056/NEJMoa2307770
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。